Korsana Plans To Take On Roche’s Trontinemab In Alzheimer’s

 
• By Joseph Haas
  
Memory loss and brain aging due to dementia and alzheimer's disease as a medical icon of a group of color changing autumn fall trees shaped as a human head losing leaves on a white background.
Korsana goes public via reverse merger with Cyclerion and initial focus on Alzheimer's
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business